4-carbamoylimidazolium 5-olate has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kimura, K; Miyazaki, T; Ogawa, M; Ohno, R; Ota, K; Sakai, Y; Suzuoki, Y; Uzuka, Y; Yamada, K; Yoshida, T | 1 |
1 trial(s) available for 4-carbamoylimidazolium 5-olate and Adenocarcinoma
Article | Year |
---|---|
[Phase I study and early phase II of SM-108 (4-carbamoylimidazolium-5-olate) in lung cancer. SM-108 Study Group].
Topics: Adenocarcinoma; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Evaluation; Female; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Purines | 1989 |